Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration’s “accelerated approval” pathway — the program responsible for bringing promising medicines to patients years ahead of schedule.

The accelerated approval pathway is a rare example of government working efficiently. Ensnaring it in red tape is senseless — and could delay patient access to lifesaving treatments.